SiTime
-
Benchmark Initiates Buy Rating on SiTime (SITM) with $850 Price Target
Benchmark analyst Gary Mobley initiated coverage of the timing-chip specialist, calling it a "technology disruptor." SiTime stock slid more than 3% to $598.29 in late morning trades following the repo
-
Macom (MTSI) and SiTime (SITM) shares jumped after positive earnings reports, helping chip stocks stage a comeback with the Philadelphia semiconductor index (SOX) rising 1.2%.
Macom (MTSI) and SiTime (SITM) shares jumped after positive earnings reports, helping chip stocks stage a comeback with the Philadelphia semiconductor index (SOX) rising 1.2%.
-
Benchmark Initiates Buy Rating on SiTime (SITM) with $850 Price Target
Benchmark analyst Gary Mobley initiated coverage of the timing-chip specialist, calling it a "technology disruptor." SiTime stock slid more than 3% to $598.29 in late morning trades following the repo
-
Macom (MTSI) and SiTime (SITM) shares jumped after positive earnings reports, helping chip stocks stage a comeback with the Philadelphia semiconductor index (SOX) rising 1.2%.
Macom (MTSI) and SiTime (SITM) shares jumped after positive earnings reports, helping chip stocks stage a comeback with the Philadelphia semiconductor index (SOX) rising 1.2%.
- No data
SiTime
24H Trending
-
1
ETH (Ethereum) surged 5.31% in 1 hour, currently trading at $2,439.61
-
2
Wingtech rejects Nexperia restructuring, cites ‘discrimination’ towards Chinese investors
-
3
What Elements Are Included in Tokenomics? How to Use It to Identify Valuable Digital Currencies
-
4
Spot gold gained 2% to break through the $4,000 threshold, while silver surged 4% as the Democrats winning control of Congress dragged down the US dollar.
-
5
Iran says US response to Strait of Hormuz opening plan lacks sincerity; Donald Trump confirms US military strikes
-
6
How to buy and sell HERO? First distinguish the project, then check the listing channels
-
7
Why are various blockchain protocols launching native stablecoins?
-
8
CVS Health plans to split into two independent publicly traded companies by early 2028, reversing its $78 billion acquisition of Aetna.
-
9
Cosmos (ATOM) Outlook Analysis: Tokenomics Restructuring and Cross-Chain Upgrades
-
10
DeFi Losses Nearing $600M in a Single Month: April 2026 Security Incidents Sound Alarm Bells for Cross-Chain and Governance
Markets Today
Recommended Reading


